Abstract
In this study, six new 2,6-disubstituted thiosemicarbazone derivatives of pyridine were synthesized (4–9), and their tuberculostatic activity was evaluated. All of them showed two- to eightfold higher activity (minimum inhibitory concentration (MIC) 0.5–4 µg/mL) against the resistant strain compared with the reference drug. Compounds 5 and 7, which contained the most basic substituents—pyrrolidine and piperidine—in their structure, strongly inhibited the growth of the standard strain (MIC 2 µg/mL). Furthermore, the same derivatives exhibited activity comparable to that of the reference drugs against some types of Gram-positive bacteria (MIC 0.49 µg/mL) and showed no cytotoxicity (IC50 > 50 µg/mL) in HaCaT cells. The zwitterionic structure of each compound was determined using X-ray crystallography. Absorption, distribution, metabolism, and excretion analyses showed that all compounds are good drug candidates. Thus, compounds 5 and 7 were identified as leading structures for further research on antituberculosis drugs with extended effects.
Subject
General Materials Science
Reference41 articles.
1. Mycobacterium tuberculosis: An Adaptable Pathogen Associated with Multiple Human Diseases;Qiya;Front. Cell. Infect. Microbiol.,2018
2. Immune evasion and provocation by Mycobacterium tuberculosis;Chandra;Nat. Rev. Microbiol.,2022
3. World Health Organization (2022). Global Tuberculosis Report 2022, World Health Organization. Available online: https://www.who.int/publications/i/item/9789240061729.
4. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current status and future prospects;Yew;Kekkaku,2011
5. Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment;Torrelles;Front. Microbiol.,2021
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献